LEADER 06548nam 2202065z- 450 001 9910557309503321 005 20231214133513.0 035 $a(CKB)5400000000042761 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68463 035 $a(EXLCZ)995400000000042761 100 $a20202105d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRole of Medical Imaging in Cancers$hVolume 2 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 electronic resource (228 p.) 311 $a3-0365-0206-8 311 $a3-0365-0207-6 330 $aThe issue of Cancers Journal entitled ?Role of Medical Imaging in Cancers? presents a detailed summary of evidences about molecular imaging, including the role of computed tomography (CT), magnetic resonance imaging (MRI), single photon emission tomography (SPET) and positron emission tomography (PET) or PET/CT or PET/MR imaging in many type of tumors (i.e. sarcoma, prostate, breast and others), motivating the role of these imaging modalities in different setting of disease and showing the recent developments, in terms of radiopharmaceuticals, software and artificial intelligence in this field. The collection of articles is very useful for many specialists, because it has been conceived for a multidisciplinary point of view, in order to drive to a personalized medicine. 606 $aMedicine 610 $apositron emission tomography 610 $ahead and neck neoplasms 610 $aneovascularization 610 $apathologic 610 $aPET/CT 610 $aurothelial carcinoma 610 $abladder cancer 610 $aupper tract urothelial carcinoma 610 $asurvival 610 $aPET 610 $aPSMA 610 $aprostate 610 $aDCFPyL 610 $aDCFBC 610 $aPSMA-1007 610 $aovarian cancer 610 $arelapse 610 $aSUVmax 610 $atargeted therapy 610 $aprognosis 610 $asoft tissue sarcoma (STS) 610 $apazopanib 610 $adynamic 18F-FDG PET/CT 610 $aSUV 610 $atwo-tissue compartment model 610 $amagnetic resonance imaging 610 $amachine learning 610 $adiffusion 610 $aperfusion 610 $atexture analysis 610 $asquamous cell carcinoma of the head and neck 610 $adiffusion-weighted imaging 610 $amalignant pleural mesothelioma 610 $apleural dissemination 610 $aempyema 610 $apleural effusion 610 $amCRPC 610 $aSPECT/CT 610 $aComputer-assisted diagnosis 610 $aXOFIGO 610 $aTherapy response assessment 610 $acirculating miRNAs 610 $abreast cancer 610 $aimaging parameters 610 $aPET/MRI 610 $abiomarkers 610 $atriple negative breast cancer 610 $aVCAM-1 610 $aSPECT imaging 610 $asdAbs 610 $aHounsfield unit 610 $acomputed tomography 610 $aadipose tissue 610 $aprecision oncology 610 $aFDG-PET/CT 610 $aPERCIST 610 $ametastatic breast cancer 610 $aprostate cancer 610 $a18F-FACBC 610 $arecurrence 610 $ameta-analysis 610 $areview 610 $ameningioma 610 $asomatostatin receptor 610 $aneuroimaging 610 $aradionuclide therapy 610 $abreast 610 $aimaging 610 $amarker 610 $aradiomics 610 $aYin Yang 1 610 $aPDAC 610 $aMesothelin 610 $anoninvasive imaging 610 $areceptor status 610 $amolecular imaging 610 $anuclear medicine 610 $aguidelines 610 $aoverutilization 610 $aepistemology 610 $aconsensus 610 $amantle cell lymphoma 610 $a18F-FDG PET/CT 610 $aDeauville criteria 610 $aRadium-223 610 $aFDG 610 $acastrate resistant prostate cancer 610 $aprogrammed cell death 1 receptor 610 $adiagnostic imaging 610 $aCTLA-4 Antigen 610 $aImmunotherapy 610 $aAdoptive 610 $aradioactive tracers 610 $aradionuclide imaging 610 $aCD8-Positive T-Lymphocytes 610 $aPI-RADS 610 $adiffusion kurtosis imaging 610 $adynamic contrast-enhanced magnetic resonance imaging 610 $a68Gallium-PSMA PET/CT 610 $aprostate-specific-antigen 610 $aPSA kinetics thresholds 610 $abiochemical recurrence 610 $aoptimal cutoff level 610 $anon-small-cell lung cancer 610 $acirculating tumor cells 610 $aimmunotherapy 610 $aresponse to treatment 610 $ahead and neck cancer 610 $aHPV 610 $aEBV 610 $ap16 610 $aMolecular imaging 610 $amiRNA expression 610 $aradiogenomics 610 $aradiomic 610 $adiagnosis 610 $abiomarker 610 $aglioblastoma 610 $aradiation therapy 610 $aMRI 610 $adiffusion tensor imaging 610 $aHodgkin lymphoma 610 $adiffuse large B-cell lymphoma 610 $astaging 610 $aresponse assessment 610 $alocally advanced cervical cancer 610 $aconcurrent chemoradiotherapy 610 $atreatment response 610 $afollow up 610 $acystic tumor 610 $aInternational Consensus Guidelines 610 $aintraductal papillary mucinous neoplasms 610 $apancreatic neoplasms 610 $aPD-1 610 $aPD-L1 610 $aresponse to therapy 610 $aNSCLC 610 $apositron-emission tomography 610 $asingle-photon emission computed tomography 610 $aimmune checkpoint inhibitors 610 $agold nanoparticle 610 $aheat shock protein 70 610 $aspectral-CT 615 0$aMedicine. 700 $aFanti$b Stefano$4edt$0755618 702 $aEvangelista$b Laura$4edt 702 $aFanti$b Stefano$4oth 702 $aEvangelista$b Laura$4oth 906 $aBOOK 912 $a9910557309503321 996 $aRole of Medical Imaging in Cancers$93024548 997 $aUNINA